Explore our media store

Choose your required content type and access a wide range of materials relating to our company, people, medicines and diagnostic tools.

Media Releases

All

Published on: 23 April 2018

New OCREVUS (ocrelizumab) data at AAN demonstrate significant reductions in disease activity and disability progression in relapsing multiple sclerosis

Roche announced today that new OCREVUS (ocrelizumab) data were presented at the 70th American Academy of Neurology (AAN) Annual Meeting from 21-27 April in Los Angeles, California.

Published on: 17 April 2018

FDA grants Breakthrough Therapy Designation for Roche’s Hemlibra in haemophilia A without inhibitors

Roche today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Hemlibra® (emicizumab-kxwh) for people with haemophilia A without factor VIII ...

Published on: 16 April 2018

Roche to present new data at AAN highlighting extensive research for OCREVUS and expanding neuroscience pipeline

Roche announced today that new data on its approved and investigational medicines for neurological conditions will be presented during the 70th American Academy of Neurology (AAN) Annual Meeting from ...

For media requests

+41 61 688 8888

Media Relations Team

For all general enquiries

Please call the Roche switchboard on
Phone:+41 61 688 11 11

Upcoming Events

All

26April

First quarter sales 2018

(GMT)

Basel

26July

Half year results 2018

(GMT)

Basel

17October

Third quarter sales 2018

(GMT)

Basel

Pipeline

Get up-to-date information about our Pharma and Diagnostics pipeline.

From idea to medicine - drug development at Roche.

@Roche on Twitter

Roche stories

All

Published on: 13 October 2016

Explore our media store

Media Releases

New OCREVUS (ocrelizumab) data at AAN demonstrate significant reductions in disease activity and disability progression in relapsing multiple sclerosis

FDA grants Breakthrough Therapy Designation for Roche’s Hemlibra in haemophilia A without inhibitors

Roche to present new data at AAN highlighting extensive research for OCREVUS and expanding neuroscience pipeline

Media contacts

For media requests

For all general enquiries

Upcoming Events

First quarter sales 2018

Half year results 2018

Third quarter sales 2018

Pipeline

@Roche on YouTube

@Roche on Twitter

Roche stories

Rheumatoid arthritis through the lens of an Slovenian artist